Komipharm International Co., Ltd. (KOSDAQ:041960)
South Korea flag South Korea · Delayed Price · Currency is KRW
9,450.00
-400.00 (-4.06%)
Sep 17, 2026, 3:30 PM KST

Komipharm International Revenue

Komipharm International had revenue of 16.70B KRW in the quarter ending June 30, 2026, with 22.11% growth. This brings the company's revenue in the last twelve months to 53.02B, down -3.27% year-over-year. In the year 2025, Komipharm International had annual revenue of 52.47B, down -10.74%.

Revenue (ttm)
53.02B
Revenue Growth
-3.27%
P/S Ratio
12.89
Revenue / Employee
329.30M
Employees
161
Market Cap
683.63B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202552.47B-6.31B-10.74%
Dec 31, 202458.78B16.13B37.83%
Dec 31, 202342.65B2.85B7.15%
Dec 31, 202239.80B3.95B11.03%
Dec 31, 202135.85B-1.31B-3.53%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
GC Corp.2.49T
Chabiotech1.31T
Medy-Tox251.08B
Onconic Therapeutics82.17B
Pharmicell23.94B
GI Innovation5.50B
AbClon5.31B
Kolon TissueGene4.80B
Revenue Rankings